Show source-provided references
1. Prevalence and Risk Factor of Chronic Rhinosinusitis and the Impact on Quality of Life in Students of the Medical Faculty Christian University of Indonesia in 2018
10.22270/jddt.v11i3-S.4846 ↗10. Topical corticosteroids in chronic rhinosinusitis: A randomized, double-blind, placebo-controlled trial using fluticasone propionate aqueous nasal spray
11. Safety and efficacy of a bioabsorbable fluticasone propionate-eluting sinus dressing in postoperative management of endoscopic sinus surgery: A randomized clinical trial
10.1002/alr.21963 ↗13. Drug solubility: Importance and enhancement techniques
14. Solubility enhancement techniques
16. Enhancement of solubilization and bioavailability of poorly soluble drugs by physical and chemical modifications: A recent review
17. Manganese-enhanced MRI of rat brain based on slow cerebral delivery of manganese (II) with silica-encapsulated MnxFe1–xO nanoparticles
10.1002/nbm.2932 ↗19. Nanoparticle formulation increases oral bioavailability of poorly soluble drugs: Approaches, experimental evidences and theory
10.2174/157341305774642939 ↗29. Facile Synthesis of Mesoporous Silica Nanoparticles Using Modified Sol-Gel Method: Optimization and In Vitro Cytotoxicity Studies
30. Hybrid drug carriers with temperature-controlled on–off release: A simple and reliable synthesis of PNIPAM-functionalized mesoporous silica nanoparticles
10.1016/j.reactfunctpolym.2015.11.006 ↗32. Development and characterization of pH-responsive polyethylene glycol-co-poly(methacrylic acid) polymeric network system for colon target delivery of oxaliplatin: Its acute oral toxicity study
10.1002/adv.21840 ↗33. Preparation and characterization of alginate-PVA-based semi-IPN: Controlled release pH-responsive composites
10.1007/s00289-017-2079-y ↗34. Thermosensitive injectable hydrogel containing carboplatin loaded nanoparticles: A dual approach for sustained and localized delivery with improved safety and therapeutic efficacy
10.1016/j.jddst.2020.101817 ↗35. Equator Assessment of Nanoparticles Using the Design-Expert Software
37. In-vitro cytotoxicity activity of Solanum nigrum extract against Hela cell line and Vero cell line
38. Allergic Rhinitis in Rats Is Associated with an Inflammatory Response of the Hippocampus
10.1155/2018/8750464 ↗42. Outside-in stepwise functionalization of mesoporous silica nanocarriers for matrix type sustained release of fluoroquinolone drugs
10.1039/C4TB02073A ↗43. Solid state characterization of mometasone furoate anhydrous and monohydrate forms
10.1002/jps.20470 ↗45. Organic/inorganic bioactive materials part IV: In vitro assessment of bioactivity of gelatin-calcium phosphate silicate/wollastonite hybrids
10.2478/s11532-009-0142-8 ↗47. Dissolution enhancement of a model poorly water-soluble drug, atorvastatin, with ordered mesoporous silica: Comparison of MSF with SBA-15 as drug carriers
10.1517/17425247.2015.1111335 ↗48. Microsponge: An augmented drug delivery system
49. Modified mesoporous silica nanoparticles for enhancing oral bioavailability and antihypertensive activity of poorly water soluble valsartan
10.1016/j.ejps.2016.12.015 ↗50. A G-quadruplex hydrogel via multicomponent self-assembly: Formation and zero-order controlled release
10.1021/acsami.7b00957 ↗51. Kinetic modeling on drug release from controlled drug delivery systems
52. In vitro drug release profiles of pH-sensitive hydroxyethylacryl chitosan/sodium alginate hydrogels using paracetamol as a soluble model drug
10.1016/j.ijbiomac.2017.02.061 ↗